Low-dose carboplatin reprograms tumor immune microenvironment through STING signaling pathway and synergizes with PD-1 inhibitors in lung cancer
Zhou Li, Qiuli Xu, Litang Huang, Jiajia Jin, Xueying Zuo, Qun Zhang, Liang Ye, Suhua Zhu, Ping Zhan, Jianan Ren, Tangfeng Lv, Yong Song
Topics & Concepts
Tumor microenvironmentCancer researchCarboplatinImmune systemStingLung cancerSignal transductionLungCancerBiologyMedicineImmunologyChemotherapyInternal medicineCell biologyCisplatinEngineeringAerospace engineeringinterferon and immune responsesImmune cells in cancerCytokine Signaling Pathways and Interactions